114 related articles for article (PubMed ID: 2542088)
1. A dicarba analog of beta-atrial natriuretic peptide (beta-ANP) inhibits guanosine 3',5'-cyclic monophosphate production induced by alpha-ANP in cultured rat vascular smooth muscle cells.
Kambayashi Y; Nakajima S; Ueda M; Inouye K
FEBS Lett; 1989 May; 248(1-2):28-34. PubMed ID: 2542088
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide enhances IL-1 beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
Iimura O; Kusano E; Homma S; Takeda S; Ikeda U; Shimada K; Asano Y
Kidney Blood Press Res; 1998; 21(1):36-41. PubMed ID: 9661135
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells.
Hutchinson HG; Trindade PT; Cunanan DB; Wu CF; Pratt RE
Cardiovasc Res; 1997 Jul; 35(1):158-67. PubMed ID: 9302360
[TBL] [Abstract][Full Text] [Related]
4. Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells.
Schiffrin EL; Turgeon A; Tremblay J; Deslongchamps M
Am J Physiol; 1991 Jan; 260(1 Pt 2):H58-65. PubMed ID: 1847018
[TBL] [Abstract][Full Text] [Related]
5. Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: role of cGMP.
Zhang LM; Tao H; Newman WH
Am J Physiol; 1993 Jun; 264(6 Pt 2):H1753-9. PubMed ID: 8391754
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide-dependent phosphorylation of smooth muscle cell particulate fraction proteins is mediated by cGMP-dependent protein kinase.
Sarcevic B; Brookes V; Martin TJ; Kemp BE; Robinson PJ
J Biol Chem; 1989 Dec; 264(34):20648-54. PubMed ID: 2573602
[TBL] [Abstract][Full Text] [Related]
7. Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells.
Furuya M; Takehisa M; Minamitake Y; Kitajima Y; Hayashi Y; Ohnuma N; Ishihara T; Minamino N; Kangawa K; Matsuo H
Biochem Biophys Res Commun; 1990 Jul; 170(1):201-8. PubMed ID: 2164803
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptide clearance receptor is transcriptionally down-regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells.
Kishimoto I; Yoshimasa T; Suga S; Ogawa Y; Komatsu Y; Nakagawa O; Itoh H; Nakao K
J Biol Chem; 1994 Nov; 269(45):28300-8. PubMed ID: 7961768
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide interacts with atrial natriuretic peptide receptor in cultured rat vascular smooth muscle cells.
Hirata Y; Shichiri M; Emori T; Marumo F; Kangawa K; Matsuo H
FEBS Lett; 1988 Oct; 238(2):415-8. PubMed ID: 2844607
[TBL] [Abstract][Full Text] [Related]
10. Correlation between vascular and cellular responses to atrial natriuretic peptide and to sodium nitroprusside.
Newman WH; Zhang LM; Castresana MR; Currie MG; Becker BF
Life Sci; 1994; 54(18):1351-6. PubMed ID: 8190007
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding, cGMP stimulation and receptor desensitization by atrial natriuretic peptides in cultured A10 vascular smooth muscle cells.
Neuser D; Bellemann P
FEBS Lett; 1986 Dec; 209(2):347-51. PubMed ID: 3025021
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of natriuretic peptide receptor activity in vascular cells.
Cao L; Zlock DW; Gardner DG
Hypertension; 1994 Sep; 24(3):329-38. PubMed ID: 8082940
[TBL] [Abstract][Full Text] [Related]
13. Difference in effect of atrial natriuretic peptide on cGMP in aortic and coronary smooth muscle cells.
Newman WH; Kato J; Becker BF; Currie MG
Am J Physiol; 1992 Sep; 263(3 Pt 2):H710-4. PubMed ID: 1329536
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide induces breakdown of phosphatidylinositol phosphates in cultured vascular smooth-muscle cells.
Resink TJ; Scott-Burden T; Baur U; Jones CR; Bühler FR
Eur J Biochem; 1988 Mar; 172(2):499-505. PubMed ID: 2894985
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of protein kinase C potentiates atrial natriuretic peptide-stimulated cGMP accumulation in vascular smooth-muscle cells.
Kawabe J; Ohsaki Y; Onodera S
Biochim Biophys Acta; 1992 Dec; 1175(1):81-7. PubMed ID: 1362357
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells.
Marumo T; Nakaki T; Hishikawa K; Hirahashi J; Suzuki H; Kato R; Saruta T
Endocrinology; 1995 May; 136(5):2135-42. PubMed ID: 7536663
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Itoh H; Pratt RE; Dzau VJ
J Clin Invest; 1990 Nov; 86(5):1690-7. PubMed ID: 2173726
[TBL] [Abstract][Full Text] [Related]
18. Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP.
Hirata Y; Tomita M; Takada S; Yoshimi H
Biochem Biophys Res Commun; 1985 Apr; 128(2):538-46. PubMed ID: 2581564
[TBL] [Abstract][Full Text] [Related]
19. Solubilization and molecular characterization of the atrial natriuretic peptide (ANP) receptor in human platelets: comparison with ANP receptors in rat tissues.
Schiffrin EL; Carrier F; Thibault G; Deslongchamps M
J Clin Endocrinol Metab; 1991 Feb; 72(2):484-91. PubMed ID: 1846877
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle.
Yasunari K; Kohno M; Murakawa K; Yokokawa K; Horio T; Takeda T
Hypertension; 1992 Apr; 19(4):314-9. PubMed ID: 1348239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
